In vitro effects of eicosanoids derived from different 20-carbon fatty acids on T helper type 1 and T helper type 2 cytokine production in human whole-blood cultures

Clinical and Experimental Allergy

Volumn 33, Issue 5, 2003, Pages 624-632

  Miles, E A ^a   Aston, L ^a   Calder, P C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Allergy; Asthma; Cytokine; Eicosanoid; Fatty acid; Interleukin; Leukotriene; Prostaglandin; Th1; Th2

Indexed keywords

CONCANAVALIN A; FATTY ACID; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 4; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE C5; PROSTAGLANDIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN E3; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; ASTHMA; BLOOD CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EICOSANOIDS; HUMANS; INTERFERON TYPE II; INTERLEUKINS; LEUKOTRIENES; MALE; PROSTAGLANDINS; PROSTAGLANDINS E; TH1 CELLS; TH2 CELLS;

EID: 0038579713     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01637.x     Document Type: Article

References (71)

1. Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989; 64:1452-6.
2. Burney PGJ, Chinn S, Rona RJ. Has the prevalence of asthma increased in children? Evidence from the national survey of health and growth 1973-86. Br Med J 1990; 300:1306-10.
3. Heinrich J, Hoelscher B, Frye C, Meyer I, Wjst M, Wichmann HE. Trends in prevalence of atopic diseases and allergic sensitization in children in Eastern Germany. Eur Respir J 2002; 19:1040-6.
4. Department of Health. Report on health and social subjects. 46: Nutritional Aspects of Cardiovascular Disease. Report of the Cardiovascular Review Group Committee on Medical Aspects of Food Policy. London: HMSO, 1994.
5. Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR. Dietary omega-3 polyunsaturated fatty-acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 1993; 91:651-60.
6. Lee TH, Hoover RL, Williams JD et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312:1217-24.
7. Tilley SL, Coffman TM, Koller BH. Mixed messages of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108:15-23.
8. British Nutrition Foundation. N-3 Fatty Acids and Health. London: British Nutrition Foundation, 1999.
9. Hodge L, Peat JK, Salome C. Increased consumption of polyunsaturated oils may be a cause of increased prevalence of childhood asthma. Aust NZ J Med 1994; 24:727.
10. Hodge L, Salome CM, Peat JK, Haby MM, Xuan W, Woolcock AJ. Consumption of oily fish and childhood asthma risk. Med J Aust 1996; 164:137-40.
11. Black PN, Sharp S. Dietary fat and asthma: is there a connection? Eur Respir J 1997; 10:6-12.
12. Kankaanpaa P, Sutas Y, Salminen S, Lichtenstein A, Isolauri E. Dietary fatty acids and allergy. Ann Med 1999; 31:282-7.
13. 4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet 1989; 1:584-8.
14. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340:197-206.
15. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993; 150:5321-9.
16. 2 critically depends on interleukin-2. Eur J Immunol 1995; 25:59-63.
17. 2 inhibits production of Th1 but not Th2 lymphokines. J Immunol 1991; 146:108-13.
18. + T cells inhibits acquisition of ability to produce IFN-γ and IL-2, but not IL-4 and IL-5. J Immunol 1995; 155:4604-12.
19. Mossman TR, Sad S. The expanding universe of T-cell subsets. Th1, Th2 and more. Immunol Today 1996; 17:138-47.
20. Gold KN, Weyand CM, Goronzy JJ. Modulation of helper T cell function by prostaglandins. Arthritis Rheumatism 1994; 37:925-33.
21. Parker CW, Huber MG, Godt SM. Modulation of IL-4 production in murine spleen cells by prostaglandins. Cell Immunol 1995; 160:278-85.
22. 2 may reside downstream of the PKC-dependent pathway. Cytokine 1996; 8:346-56.
23. + T cells. J Immunol 1996; 156:1722-7.
24. 4 receptor antagonist in vitro. Biochem Biophys Res Comm 1999; 264:321-63.
25. 4 induces interleukin-5 generation from human T-lymphocytes. Eur J Immunol 1993; 23:2392-8.
26. Calder PC, Miles EA. Fatty acids and atopic disease. Pediatr Allergy Immunol Supplement 2000; 13:29-36.
27. Meydani SN, Endres S, Woods MM et al. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 1991; 121:547-55.
28. Endres S, Ghorbani R, Kelley VE et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265-71.
29. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable or fish oil. Am J Clin Nutr 1996; 63:116-22.
30. Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 1997; 65:1011-7.
31. 5 and the double lipoxygenase product. J Biol Chem 1984; 259:2383-9.
32. Goldyne ME. Lymphocytes and arachidonic acid metabolism. Prog Allergy 1988; 44:140-52.
33. Goldyne ME. Eicosanoid metabolism by lymphocytes: do all human nucleated cells generate eicosanoids? Pharmacol Res 1989; 21:241-5.
34. Calder PC, Bevan SJ, Newsholme EA. The inhibition of T-lymphocyte proliferation by fatty acids is via an eicosanoid-independent mechanism. Immunology 1992; 75:108-15.
35. Miles EA, Allen E, Calder PC. In vitro effects of eicosanoids derived from different 20-carbon fatty acids on production of monocyte-derived cytokines in human whole blood cultures. Cytokine 2002; 20:215-23.
36. Jones CA, Vance GHS, Power LL, Pender SLF, MacDonald TT, Warner JO. Co-stimulatory molecules in the developing gastrointestinal tract: a pathway for fetal allergen priming. J Allergy Clin Immunol 2001; 108:235-41.
37. Kinsella JE, Lokesh B, Broughton S, Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: Potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 1990; 6:24-44.
38. Nowak D, Grimminger F, Jorres R et al. Increased LTB4 metabolites and PGD: in BAL fluid after methacholine challenge in asthmatic subjects. Eur Resp J 1993; 6:405-12.
39. Creticos PS. Clinical considerations of leukotriene modifiers in the treatment of rhinitis. Clin Exp Allergy Rev 2001; 1:235-243.
40. 2-induced inhibition of interleukin 2 production. J Immunol 1983; 130:1170-773.
41. 2 effects on human suppressor cell function and on interleukin 2 function. J Immunol 1982; 129:2469-73.
42. Rappaport RS, Dodge GR. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 1982; 155:943-8.
43. 2 acts at 2 distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and downregulation of transferrin receptor expression. J Immunol 1985; 135:1172-9.
44. DellaBella S, Molteni M, Compasso S, Zulian C, Vanoli M, Scorza R. Differential effects of cyclo-oxygenase pathway metabolites on cytokine production by T lymphocytes. Prost Leuk Essent Fatty Acids 1997; 56:177-84.
45. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J Immunol 1992; 148:2845-52.
46. 2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways. J Exp Med 1993; 178:1813-7.
47. De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992, 1989; 4:239-48.
48. Santoli D, Zurier RB. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-dependent mechanism. J Immunol 1989; 143:1303-9.
49. Smith KA. Interleukin-2: Inception, impact and implications. Science 1988; 240:1169-76.
50. Shapiro AC, Wu D, Meydani SN. Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative response. Prostaglandins 1993; 45:229-40.
51. Santoli D, Phillips PD, Colt TL, Zurier RB. Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. J Clin Invest 1990; 85:424-32.
52. + T cells. Mol Immunol 1998; 35:39-45.
53. Young HA, Ghosh P, Ye JP et al. Differentiation of the T-helper phenotypes by analysis of the methylation state of the IFN-gamma gene. J Immunol 1994; 153:3603-10.
54. Melvin AJ, McGurn ME, Bort SJ, Gibson C, Lewis DB. Hypomethylation of the interferon-gamma gene correlates with its expression by primary T cell lineage. Eur J Immunol 1995; 25:426-30.
55. + T cells. J Exp Med 1998; 188:103-17.
56. - T cells. J Immunol 2002; 168:2820-7.
57. Benbernou N, Esnault S, Shin HCK, Fekkar H, Guenounou M. Differential regulation of IFN-γ, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction. Immunol 1997; 91:361-8.
58. Novak TJ, Rothenberg EV. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc Natl Acad Sci USA 1990; 87:9353-7.
59. Falek PR, Ben-Sasson SZ, Ariel M. Correlation between DNA methylation and murine IFN-γ and IL-4 expression. Cytokine 2000; 12:198-206.
60. + T-cell-dependent interleukin-2 production in vitro by murine alveolar macrophages: the role of leukotriene B4. Immunol 1997; 91:369-74.
61. Romagnani S. The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000; 105:399-408.
62. Kelley DS, Taylor PC, Nelson GJ et al. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 1999; 34:317-24.
63. Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000; 30:260-74.
64. Mantzioris E, Cleland LG, Gibson RA, Neumann MA, Demasi M, James MJ. Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am J Clin Nutr 2000; 72:42-8.
65. Malkowski MG, Thuresson ED, Lakkides KM et al. Structure of eicosapentaenoic and linoleic acids in the cyclooxygenase site of prostaglandin endoperoxide H synthase-1. J Biol Chem 2001; 276:37547-55.
66. Corey EJ, Shih C, Cashman JR. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci USA 1983; 80:3581-4.
67. 2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy 1999; 29:1129-35.
68. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B, n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 2000; 275:721-4.
69. Curtis CL, Rees SG, Little CB et al. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arth Rheum 2002; 46:1544-53.
70. 3 following derivatization with panacyl bromide by high pressure liquid chromatography with fluorometric detection. Prostaglandins 1991; 42:355-68.
71. Dunder T, Kuikka L, Turtinen J, Rasanen L, Uhari M. Diet, serum fatty acids, and atopic diseases in childhood. Allergy 2001; 56:425-8.